Queen Mary University of London, as part of the Barts Life Sciences partnership, receives UKRI funding for data-driven healthcare in East London
UK Research and Innovation (UKRI) has awarded funding to Queen Mary University of London, as part of the Barts Life Sciences partnership, to develop a proposal for data-driven next generation healthcare in Whitechapel.
Led by Barts Life Sciences, the project will harness artificial intelligence and data technology to provide better healthcare for patients living in East London, specifically Whitechapel, where chronic health problems are significantly higher than the national average. Through the funding, it will create a space for academics, clinicians and industry to work together with the local hospitals to develop and test new treatments.
The project was one of seventeen new projects that will harness research and innovation excellence to boost local growth have been given early stage investment from UKRI’s Strength in Places Fund. The projects will receive up to £50k each to develop full-stage bid, in this case c. £21m.
The 17 consortia are spread across the UK and include central and southern Scotland, south Wales, Northern Ireland, England’s north-west, north-east, south-east, south-west and the Midlands. Their projects will build on local strengths in industry and research to create significant economic impact, drive local growth, provide skills training and create high-value jobs.